Report Detail

Request for Sample of this report

Other Global Group B Streptococcus (GBS) Infection Treatment Key Trends and Opportunities to 2027

  • RnM3950175
    • |
  • 22 March, 2021
    • |
  • Global
    • |
  • 155 Pages
    • |
  • QYResearch
    • |
  • Other

Group B Streptococcus (GBS) Infection Treatment market is segmented by companies, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Group B Streptococcus (GBS) Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on market size and forecast for the period 2016-2027.
Segment by Type, the Group B Streptococcus (GBS) Infection Treatment market is segmented into Prenatal-onset Gbs Disease, Early-onset Gbs Disease, Late-onset Gbs Disease, etc.
Segment by Application, the Group B Streptococcus (GBS) Infection Treatment market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, etc.

Regional and Country-level Analysis
The report offers exhaustive assessment of different region-wise and country-wise Group B Streptococcus (GBS) Infection Treatment markets such as the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Saudi Arabia, UAE, Turkey, etc.
The report includes country-wise and region-wise market size for the period 2016-2027, by countries (regions), by Type, and by Application, as well as by players for North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Competitive Landscape and Group B Streptococcus (GBS) Infection Treatment Market Share Analysis
Group B Streptococcus (GBS) Infection Treatment market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2016-2021. Details included are company description, major business, company total revenue and revenue generated in Group B Streptococcus (GBS) Infection Treatment business, the date to enter into the Group B Streptococcus (GBS) Infection Treatment market, Group B Streptococcus (GBS) Infection Treatment product introduction, recent developments, etc.
The major vendors include Pfizer Inc., Alopexx Enterprises, LLC, Wellstat Vaccines LLC, Minervax ApS, Novartis, GlaxoSmithKline, etc.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Prenatal-onset Gbs Disease
    • 1.2.3 Early-onset Gbs Disease
    • 1.2.4 Late-onset Gbs Disease
  • 1.3 Market by Application
    • 1.3.1 Global Group B Streptococcus (GBS) Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trend

  • 2.1 Global Group B Streptococcus (GBS) Infection Treatment Market Perspective (2016-2027)
  • 2.2 Global Group B Streptococcus (GBS) Infection Treatment Growth Trends by Regions
    • 2.2.1 Group B Streptococcus (GBS) Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Group B Streptococcus (GBS) Infection Treatment Historic Market Size by Regions (2016-2021)
    • 2.2.3 Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Regions (2022-2027)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Group B Streptococcus (GBS) Infection Treatment Industry Trends
    • 2.3.2 Group B Streptococcus (GBS) Infection Treatment Market Drivers
    • 2.3.3 Group B Streptococcus (GBS) Infection Treatment Market Challenges
    • 2.3.4 Group B Streptococcus (GBS) Infection Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Group B Streptococcus (GBS) Infection Treatment Players by Market Size
    • 3.1.1 Players Covered: Ranking by Group B Streptococcus (GBS) Infection Treatment Revenue
    • 3.1.2 Global Top Group B Streptococcus (GBS) Infection Treatment Players by Revenue (2016-2021)
    • 3.1.3 Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Players (2016-2021)
    • 3.1.4 Global Group B Streptococcus (GBS) Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Group B Streptococcus (GBS) Infection Treatment Market Concentration Ratio
    • 3.2.1 Global Group B Streptococcus (GBS) Infection Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 5 and Top 10 Players by Group B Streptococcus (GBS) Infection Treatment Revenue in 2020
  • 3.3 Group B Streptococcus (GBS) Infection Treatment Key Players Head office and Area Served
  • 3.4 Key Players Group B Streptococcus (GBS) Infection Treatment Product Solution and Service
  • 3.5 Date of Enter into Group B Streptococcus (GBS) Infection Treatment Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Global Group B Streptococcus (GBS) Infection Treatment Breakdown Data by Type (2016-2027)

  • 4.1 Global Group B Streptococcus (GBS) Infection Treatment Historic Market Size by Type (2016-2021)
  • 4.2 Global Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Type (2022-2027)

5 Global Group B Streptococcus (GBS) Infection Treatment Breakdown Data by Application (2016-2027)

  • 5.1 Global Group B Streptococcus (GBS) Infection Treatment Historic Market Size by Application (2016-2021)
  • 5.2 Group B Streptococcus (GBS) Infection Treatment Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
  • 6.2 Key Group B Streptococcus (GBS) Infection Treatment Players Market Share in North America (2020-2021)
  • 6.3 North America Group B Streptococcus (GBS) Infection Treatment Market Size by Country
    • 6.3.1 North America Group B Streptococcus (GBS) Infection Treatment Sales by Country (2016-2021)
    • 6.3.2 North America Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country (2022-2027)
  • 6.4 U.S. Market Size Analysis
    • 6.4.1 U.S. Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 6.4.2 U.S. Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 6.4.3 U.S. Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 6.5 Canada Market Size Analysis
    • 6.5.1 Canada Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 6.5.2 Canada Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 6.5.3 Canada Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)

7 Europe

  • 7.1 Europe Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
  • 7.2 Key Group B Streptococcus (GBS) Infection Treatment Players Market Share in Europe (2020-2021)
  • 7.3 Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Country
    • 7.3.1 Europe Group B Streptococcus (GBS) Infection Treatment Sales by Country (2016-2021)
    • 7.3.2 Europe Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country (2022-2027)
  • 7.4 Germany Market Size Analysis
    • 7.4.1 Germany Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 7.4.2 Germany Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 7.4.3 Germany Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 7.5 France Market Size Analysis
    • 7.5.1 France Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 7.5.2 France Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 7.5.3 France Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 7.6 U.K. Market Size Analysis
    • 7.6.1 U.K. Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 7.6.2 U.K. Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 7.6.3 U.K. Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 7.7 Italy Market Size Analysis
    • 7.7.1 Italy Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 7.7.2 Italy Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 7.7.3 Italy Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 7.8 Russia Market Size Analysis
    • 7.8.1 Russia Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 7.8.2 Russia Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 7.8.3 Russia Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)

8 Asia-Pacific

  • 8.1 Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
  • 8.2 Key Group B Streptococcus (GBS) Infection Treatment Players Market Share in Asia-Pacific (2020-2021)
  • 8.3 Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Sales by Region (2016-2021)
    • 8.3.2 Asia-Pacific Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Region (2022-2027)
  • 8.4 China Market Size Analysis
    • 8.4.1 China Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 8.4.2 China Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 8.4.3 China Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 8.5 Japan Market Size Analysis
    • 8.5.1 Japan Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 8.5.2 Japan Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 8.5.3 Japan Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 8.6 South Korea Market Size Analysis
    • 8.6.1 South Korea Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 8.6.2 South Korea Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 8.6.3 South Korea Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 8.7 India Market Size Analysis
    • 8.7.1 India Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 8.7.2 India Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 8.7.3 India Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 8.8 Australia Market Size Analysis
    • 8.8.1 Australia Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 8.8.2 Australia Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 8.8.3 Australia Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 8.9 Taiwan Market Size Analysis
    • 8.9.1 Taiwan Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 8.9.2 Taiwan Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 8.9.3 Taiwan Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 8.10 Indonesia Market Size Analysis
    • 8.10.1 Indonesia Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 8.10.2 Indonesia Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 8.10.3 Indonesia Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 8.11 Thailand Market Size Analysis
    • 8.11.1 Thailand Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 8.11.2 Thailand Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 8.11.3 Thailand Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 8.12 Malaysia Market Size Analysis
    • 8.12.1 Malaysia Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 8.12.2 Malaysia Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 8.12.3 Malaysia Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 8.13 Philippines Market Size Analysis
    • 8.13.1 Philippines Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 8.13.2 Philippines Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 8.13.3 Philippines Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 8.14 Vietnam Market Size Analysis
    • 8.14.1 Vietnam Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 8.14.2 Vietnam Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 8.14.3 Vietnam Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)

9 Latin America

  • 9.1 Latin America Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
  • 9.2 Key Group B Streptococcus (GBS) Infection Treatment Players Market Share in Latin America (2020-2021)
  • 9.3 Latin America Group B Streptococcus (GBS) Infection Treatment Market Size by Country
    • 9.3.1 Latin America Group B Streptococcus (GBS) Infection Treatment Sales by Country (2016-2021)
    • 9.3.2 Latin America Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country (2022-2027)
  • 9.4 Mexico Market Size Analysis
    • 9.4.1 Mexico Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 9.4.2 Mexico Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 9.4.3 Mexico Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 9.5 Brazil Market Size Analysis
    • 9.5.1 Brazil Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 9.5.2 Brazil Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 9.5.3 Brazil Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 9.6 Argentina Market Size Analysis
    • 9.6.1 Argentina Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 9.6.2 Argentina Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 9.6.3 Argentina Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)

10 Middle East & Africa

  • 10.1 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
  • 10.2 Key Group B Streptococcus (GBS) Infection Treatment Players Market Share in Middle East & Africa (2020-2021)
  • 10.3 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Sales by Country (2016-2021)
    • 10.3.2 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Country (2022-2027)
  • 10.4 Turkey Market Size Analysis
    • 10.4.1 Turkey Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 10.4.2 Turkey Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 10.4.3 Turkey Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 10.5 Saudi Arabia Market Size Analysis
    • 10.5.1 Saudi Arabia Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 10.5.2 Saudi Arabia Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 10.5.3 Saudi Arabia Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)
  • 10.6 UAE Market Size Analysis
    • 10.6.1 UAE Group B Streptococcus (GBS) Infection Treatment Market Size (2016-2027)
    • 10.6.2 UAE Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2016-2027)
    • 10.6.3 UAE Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2016-2027)

11 Key Players Profiles

  • 11.1 Pfizer Inc.
    • 11.1.1 Pfizer Inc. Company Details
    • 11.1.2 Pfizer Inc. Business Overview and Its Total Revenue
    • 11.1.3 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Introduction
    • 11.1.4 Pfizer Inc. Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2016-2021)
    • 11.1.5 Pfizer Inc. Recent Development
  • 11.2 Alopexx Enterprises, LLC
    • 11.2.1 Alopexx Enterprises, LLC Company Details
    • 11.2.2 Alopexx Enterprises, LLC Business Overview and Its Total Revenue
    • 11.2.3 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Introduction
    • 11.2.4 Alopexx Enterprises, LLC Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2016-2021)
    • 11.2.5 Alopexx Enterprises, LLC Recent Development
  • 11.3 Wellstat Vaccines LLC
    • 11.3.1 Wellstat Vaccines LLC Company Details
    • 11.3.2 Wellstat Vaccines LLC Business Overview and Its Total Revenue
    • 11.3.3 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Introduction
    • 11.3.4 Wellstat Vaccines LLC Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2016-2021)
    • 11.3.5 Wellstat Vaccines LLC Recent Development
  • 11.4 Minervax ApS
    • 11.4.1 Minervax ApS Company Details
    • 11.4.2 Minervax ApS Business Overview and Its Total Revenue
    • 11.4.3 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Introduction
    • 11.4.4 Minervax ApS Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2016-2021)
    • 11.4.5 Minervax ApS Recent Development
  • 11.5 Novartis
    • 11.5.1 Novartis Company Details
    • 11.5.2 Novartis Business Overview and Its Total Revenue
    • 11.5.3 Novartis Group B Streptococcus (GBS) Infection Treatment Introduction
    • 11.5.4 Novartis Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2016-2021)
    • 11.5.5 Novartis Recent Development
  • 11.6 GlaxoSmithKline
    • 11.6.1 GlaxoSmithKline Company Details
    • 11.6.2 GlaxoSmithKline Business Overview and Its Total Revenue
    • 11.6.3 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Introduction
    • 11.6.4 GlaxoSmithKline Revenue in Group B Streptococcus (GBS) Infection Treatment Business (2016-2021)
    • 11.6.5 GlaxoSmithKline Recent Development

12 Analyst's Viewpoints/Conclusion

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source

    Summary:
    Get latest Market Research Reports on Group B Streptococcus (GBS) Infection Treatment. Industry analysis & Market Report on Group B Streptococcus (GBS) Infection Treatment is a syndicated market report, published as Global Group B Streptococcus (GBS) Infection Treatment Key Trends and Opportunities to 2027. It is complete Research Study and Industry Analysis of Group B Streptococcus (GBS) Infection Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$6,600.00
    		$9,900.00
    		$13,200.00
    		5,167.80
    		7,751.70
    		10,335.60
    		6,217.20
    		9,325.80
    		12,434.40
    		1,019,304.00
    		1,528,956.00
    		2,038,608.00
    		557,172.00
    		835,758.00
    		1,114,344.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo